Keith L. Lui

Corporate Officer/Principal presso DURECT CORPORATION

Health Technology

Consumer Services

Profilo

Keith L.
Lui is currently working as the SVP-Business Development & Medical Affairs at DURECT Corp.
Prior to this, he held the position of Vice President-Marketing at Pharmacyclics LLC.
From 2014 to 2017, he served as the Vice President-Marketing at Versartis, Inc. Mr. Lui completed his undergraduate degree at the University of California, Berkeley and obtained an MBA from Vanderbilt Owen Graduate School of Management.

Posizioni attive di Keith L. Lui

Società	Posizione	Inizio
DURECT CORPORATION	Corporate Officer/Principal	01/05/2020

Tutte le posizioni attive di Keith L. Lui

Precedenti posizioni note di Keith L. Lui

Società	Posizione	Fine
Versartis, Inc. Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.	Vendite & Marketing	01/07/2017
PHARMACYCLICS, INC.	Vendite & Marketing	-

Vedi nel dettaglio l'esperienza di Keith L. Lui

Formazione di Keith L. Lui

University of California, Berkeley	Undergraduate Degree
Vanderbilt Owen Graduate School of Management	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Keith L. Lui

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
DURECT CORPORATION	Health Technology

Aziende private	2
Versartis, Inc. Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.	Health Technology
Pharmacyclics LLC Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA.	Health Technology